A detailed history of Voloridge Investment Management, LLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 26,514 shares of RVMD stock, worth $1.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,514
Previous 40,285 34.18%
Holding current value
$1.5 Million
Previous $1.56 Million 23.16%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$36.92 - $47.94 $508,425 - $660,181
-13,771 Reduced 34.18%
26,514 $1.2 Million
Q2 2024

Aug 14, 2024

SELL
$30.14 - $40.68 $920,716 - $1.24 Million
-30,548 Reduced 43.13%
40,285 $1.56 Million
Q1 2024

May 15, 2024

BUY
$26.56 - $33.55 $1.88 Million - $2.38 Million
70,833 New
70,833 $2.28 Million
Q1 2023

May 15, 2023

SELL
$20.76 - $30.09 $1.43 Million - $2.08 Million
-69,077 Reduced 71.87%
27,033 $585,000
Q4 2022

Feb 14, 2023

SELL
$17.68 - $25.53 $2.73 Million - $3.94 Million
-154,461 Reduced 61.64%
96,110 $2.29 Million
Q3 2022

Nov 14, 2022

BUY
$17.46 - $26.0 $2.42 Million - $3.6 Million
138,437 Added 123.46%
250,571 $4.94 Million
Q2 2022

Aug 15, 2022

BUY
$14.54 - $27.17 $280,752 - $524,625
19,309 Added 20.8%
112,134 $2.19 Million
Q1 2022

May 16, 2022

BUY
$17.31 - $26.4 $1.61 Million - $2.45 Million
92,825 New
92,825 $2.37 Million
Q4 2021

Feb 14, 2022

SELL
$24.35 - $33.7 $1.3 Million - $1.8 Million
-53,384 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$23.95 - $33.41 $950,407 - $1.33 Million
39,683 Added 289.64%
53,384 $1.47 Million
Q2 2021

Aug 16, 2021

SELL
$29.0 - $47.44 $1.06 Million - $1.73 Million
-36,440 Reduced 72.68%
13,701 $435,000
Q1 2021

May 17, 2021

SELL
$37.21 - $54.43 $1.38 Million - $2.02 Million
-37,194 Reduced 42.59%
50,141 $2.3 Million
Q4 2020

Feb 16, 2021

BUY
$30.19 - $45.49 $2.64 Million - $3.97 Million
87,335 New
87,335 $3.46 Million

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $4.95B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.